checkAd

    EQS-News  129  0 Kommentare CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00

    Für Sie zusammengefasst
    • Shareholders approve dividend doubling to EUR 1.00
    • High approval rates for capital measures
    • Focus on data-based solutions and artificial intelligence

    EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM
    CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00

    22.05.2024 / 13:43 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00

    Anzeige 
    Handeln Sie Ihre Einschätzung zu CompuGroup Medical!
    Long
    22,89€
    Basispreis
    0,19
    Ask
    × 12,91
    Hebel
    Short
    26,15€
    Basispreis
    0,20
    Ask
    × 12,26
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    • Acts of the governing boards formally approved
    • Dividend proposal of EUR 1.00 confirmed
    • High approval rates for capital measures
    • Focus on data-based solutions and artificial intelligence

     

    Koblenz - The shareholders of CompuGroup Medical SE & Co. KGaA (CGM) approved the dividend proposal of the General Partner, the Supervisory Board and the Managing Directors at the e-health group's virtual Annual General Meeting (AGM) on May 22, 2024. As a result, a dividend of EUR 1.00 per share will be paid for the financial year 2023, twice as much as in the previous year. This corresponds to a payout of around EUR 51.7 million. The shareholders also approved all proposed capital measures by majorities of more than 90 percent such as the enactment of authorized capital, the authorization to issue convertible bonds and share options or the authorization to acquire and use treasury shares.

    The shareholders approved the annual financial statements of CompuGroup Medical SE & Co. KGaA for 2023 and passed the remuneration report for 2023. The actions of the General Partner of CompuGroup Medical SE & Co. KGaA and the members of the Supervisory Board were formally approved.

    All other items on the agenda were also approved by the shareholders with a large majority. A total of around 79 percent of the share capital of CompuGroup Medical SE & Co. KGaA was represented at the Annual General Meeting. The speeches by CEO Michael Rauch and CFO Daniela Hommel, who has been in office since February 1, were published beforehand online. A video replay of both speeches will be made avaailable subsequently on the company's website.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00 EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00 22.05.2024 / 13:43 CET/CEST The issuer is solely responsible for the content of this …

    Schreibe Deinen Kommentar

    Disclaimer